{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:44:52Z","timestamp":1773884692251,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30AI140829"],"award-info":[{"award-number":["F30AI140829"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI112566"],"award-info":[{"award-number":["R01AI112566"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI068614"],"award-info":[{"award-number":["AI068614"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI068618"],"award-info":[{"award-number":["AI068618"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI068635"],"award-info":[{"award-number":["AI068635"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>HLA-I\u2013associated human immunodeficiency virus (HIV) adaptation is known to negatively affect disease progression and CD8 T-cell responses. We aimed to assess how HLA-I\u2013associated adaptation affects HIV vaccine\u2013induced CD8 T-cell responses in 2 past vaccine efficacy trials. We found that vaccine-encoded adapted epitopes were less immunogenic than vaccine-encoded nonadapted epitopes, and adapted epitope-specific responses were less polyfunctional than nonadapted epitope-specific responses. Along those lines, vaccine recipients with higher HLA-I adaptation to the Gag vaccine insert mounted less polyfunctional CD8 T-cell responses at the protein level. Breadth of response, which correlated with viral control in recipients who became infected, is also dampened by HLA-I adaptation. These findings suggest that HLA-I\u2013associated adaptation is an important consideration for strategies aiming to induce robust CD8 T-cell responses.<\/jats:p>","DOI":"10.1093\/infdis\/jiz368","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T03:09:54Z","timestamp":1562814594000},"page":"1620-1628","source":"Crossref","is-referenced-by-count":13,"title":["HLA-I Associated Adaptation Dampens CD8 T-Cell Responses in HIV Ad5-Vectored Vaccine Recipients"],"prefix":"10.1093","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1525-0523","authenticated-orcid":false,"given":"Sushma","family":"Boppana","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Sterrett","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Files","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Qin","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7627-2166","authenticated-orcid":false,"given":"Andrew","family":"Fiore-Gartland","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen W","family":"Cohen","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C","family":"De Rosa","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Bansal","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8142-0386","authenticated-orcid":false,"given":"Paul A","family":"Goepfert","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"2019100813084883600_CIT0001","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/QAD.0000000000000987","article-title":"Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir","volume":"30","author":"Calin","year":"2016","journal-title":"AIDS"},{"key":"2019100813084883600_CIT0002","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"2019100813084883600_CIT0003","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"2019100813084883600_CIT0004","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol"},{"key":"2019100813084883600_CIT0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.immuni.2015.08.012","article-title":"Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point","volume":"43","author":"Ndhlovu","year":"2015","journal-title":"Immunity"},{"key":"2019100813084883600_CIT0006","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"key":"2019100813084883600_CIT0007","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J Exp Med"},{"key":"2019100813084883600_CIT0008","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature07469","article-title":"Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys","volume":"457","author":"Liu","year":"2009","journal-title":"Nature"},{"key":"2019100813084883600_CIT0009","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"Goonetilleke","year":"2009","journal-title":"J Exp Med"},{"key":"2019100813084883600_CIT0010","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1128\/JVI.79.21.13239-13249.2005","article-title":"Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution","volume":"79","author":"Allen","year":"2005","journal-title":"J Virol"},{"key":"2019100813084883600_CIT0011","doi-asserted-by":"crossref","first-page":"e1002529","DOI":"10.1371\/journal.ppat.1002529","article-title":"Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection","volume":"8","author":"Henn","year":"2012","journal-title":"PLoS Pathog"},{"key":"2019100813084883600_CIT0012","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nm.2316","article-title":"Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial","volume":"17","author":"Rolland","year":"2011","journal-title":"Nat Med"},{"key":"2019100813084883600_CIT0013","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/infdis\/jit322","article-title":"Vaccine-induced Gag-specific T cells are associated with reduced viremia after HIV-1 infection","volume":"208","author":"Janes","year":"2013","journal-title":"J Infect Dis"},{"key":"2019100813084883600_CIT0014","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/infdis\/jix086","article-title":"Higher T-cell responses induced by DNA\/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial","volume":"215","author":"Janes","year":"2017","journal-title":"J Infect Dis"},{"key":"2019100813084883600_CIT0015","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1069660","article-title":"Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level","volume":"296","author":"Moore","year":"2002","journal-title":"Science"},{"key":"2019100813084883600_CIT0016","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nature07746","article-title":"Adaptation of HIV-1 to human leukocyte antigen class I","volume":"458","author":"Kawashima","year":"2009","journal-title":"Nature"},{"key":"2019100813084883600_CIT0017","doi-asserted-by":"crossref","first-page":"E5393","DOI":"10.1073\/pnas.1413339111","article-title":"Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence","volume":"111","author":"Payne","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019100813084883600_CIT0018","doi-asserted-by":"crossref","first-page":"e1004295","DOI":"10.1371\/journal.pgen.1004295","article-title":"Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic","volume":"10","author":"Cotton","year":"2014","journal-title":"PLoS Genet"},{"key":"2019100813084883600_CIT0019","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1073\/pnas.050567397","article-title":"HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors","volume":"97","author":"Migueles","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019100813084883600_CIT0020","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1126\/science.1195271","article-title":"The major genetic determinants of HIV-1 control affect HLA class I peptide presentation","volume":"330","author":"Pereyra","year":"2010","journal-title":"Science"},{"key":"2019100813084883600_CIT0021","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1371\/journal.pmed.0030403","article-title":"HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8+ T cell response against HIV-1","volume":"3","author":"Altfeld","year":"2006","journal-title":"PLoS Med"},{"key":"2019100813084883600_CIT0022","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nm.4100","article-title":"Impact of pre-adapted HIV transmission","volume":"22","author":"Carlson","year":"2016","journal-title":"Nat Med"},{"key":"2019100813084883600_CIT0023","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/icb.2011.34","article-title":"High-avidity, high-IFN\u03b3-producing CD8 T-cell responses following immune selection during HIV-1 infection","volume":"90","author":"Keane","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"2019100813084883600_CIT0024","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm.2108","article-title":"Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys","volume":"16","author":"Santra","year":"2010","journal-title":"Nat Med"},{"key":"2019100813084883600_CIT0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"Barouch","year":"2010","journal-title":"Nat Med"},{"key":"2019100813084883600_CIT0026","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"2019100813084883600_CIT0027","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"N Engl J Med"},{"key":"2019100813084883600_CIT0028","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-61779-937-2_25","article-title":"Protocol for analyzing human leukocyte antigen variants and sexually transmitted infections: from genotyping to immunoassays","volume":"903","author":"Tang","year":"2012","journal-title":"Methods Mol Biol"},{"key":"2019100813084883600_CIT0029","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/JVI.03435-14","article-title":"Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1","volume":"89","author":"Berger","year":"2015","journal-title":"J Virol"},{"key":"2019100813084883600_CIT0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1089\/cmb.2007.R013","article-title":"Leveraging information across HLA alleles\/supertypes improves epitope prediction","volume":"14","author":"Heckerman","year":"2007","journal-title":"J Comput Biol"},{"key":"2019100813084883600_CIT0031","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/bioinformatics\/btx168","article-title":"SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials","volume":"33","author":"Fiore-Gartland","year":"2017","journal-title":"Bioinformatics"},{"key":"2019100813084883600_CIT0032","article-title":"HIV sequence compendium. Los Alamos National Laboratory, NM, LA-UR 18-25673","author":"Foley","year":"2018"},{"key":"2019100813084883600_CIT0033","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/QAD.0b013e3282f13823","article-title":"Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents","volume":"21","author":"Bansal","year":"2007","journal-title":"AIDS"},{"key":"2019100813084883600_CIT0034","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1128\/JVI.00068-08","article-title":"Multifunctional T-cell characteristics induced by a polyvalent DNA prime\/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration","volume":"82","author":"Bansal","year":"2008","journal-title":"J Virol"},{"key":"2019100813084883600_CIT0035","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.4049\/jimmunol.1502411","article-title":"HIV-1-specific CD8 T cells exhibit limited cross-reactivity during acute infection","volume":"196","author":"Du","year":"2016","journal-title":"J Immunol"},{"key":"2019100813084883600_CIT0036","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nbt.3187","article-title":"COMPASS identifies T-cell subsets correlated with clinical outcomes","volume":"33","author":"Lin","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2019100813084883600_CIT0037","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1086\/587993","article-title":"Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag\/pol\/nef vaccine in healthy adults","volume":"46","author":"Priddy","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2019100813084883600_CIT0038","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"key":"2019100813084883600_CIT0039","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover","volume":"204","author":"Almeida","year":"2007","journal-title":"J Exp Med"},{"key":"2019100813084883600_CIT0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2012.11.021","article-title":"A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells","volume":"38","author":"Ladell","year":"2013","journal-title":"Immunity"},{"key":"2019100813084883600_CIT0041","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/21645515.2018.1489949","article-title":"Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV able to recognize virus-infected cells in macaques","volume":"14","author":"Hu","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2019100813084883600_CIT0042","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1371\/journal.ppat.0030157","article-title":"HIV-1 group M conserved elements vaccine","volume":"3","author":"Rolland","year":"2007","journal-title":"PLoS Pathog"},{"key":"2019100813084883600_CIT0043","doi-asserted-by":"crossref","first-page":"1254031","DOI":"10.1126\/science.1254031","article-title":"HIV transmission: selection bias at the heterosexual HIV-1 transmission bottleneck","volume":"345","author":"Carlson","year":"2014","journal-title":"Science"},{"key":"2019100813084883600_CIT0044","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.20072457","article-title":"Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients","volume":"205","author":"Goepfert","year":"2008","journal-title":"J Exp Med"},{"key":"2019100813084883600_CIT0045","doi-asserted-by":"crossref","first-page":"e1000033","DOI":"10.1371\/journal.ppat.1000033","article-title":"Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage","volume":"4","author":"Chopera","year":"2008","journal-title":"PLoS Pathog"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz368\/30038479\/jiz368.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/10\/1620\/30120933\/jiz368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/10\/1620\/30120933\/jiz368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T12:41:50Z","timestamp":1610368910000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/220\/10\/1620\/5532017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,7,12]]},"published-print":{"date-parts":[[2019,10,8]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz368","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11,15]]},"published":{"date-parts":[[2019,7,12]]}}}